Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT04537130
Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge
Phase: Phase 1
Role: Collaborator
Start: Dec 1, 2020
Completion: Jun 30, 2022